Investing.com - United Therapeutics (NASDAQ:UTHR) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
United Therapeutics announced earnings per share of $4.91 on revenue of $516M. Analysts polled by Investing.com anticipated EPS of $4.06 on revenue of $493.81M.
United Therapeutics shares are up 5% from the beginning of the year, still down 6.96% from its 52 week high of $245.48 set on July 8.
United Therapeutics follows other major Healthcare sector earnings this month
United Therapeutics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar